Update on real-world efficacy of anlotinib in non-small cell lung cancer

被引：0
|
作者：
Gao, Junzhen
Xu, Yan
Liu, Yonggang
Liang, Li
Yu, Yan
Zhao, Dahai
Jin, Jiahui
Wang, Mengzhao
机构：
[1] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[3] Baotou Tumor Hosp, Baotou, Peoples R China
[4] Peking Univ Third Hosp, Beijing, Peoples R China
[5] Harbin Med Canc Hosp, Harbin, Peoples R China
[6] Second Affiliated Hosp, Hefei, Peoples R China
[7] Affiliated Qingdao Cent Hosp, Qingdao, Peoples R China
[8] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21173
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer
    Wei, Xiao
    Zhao, Yun
    Yan, Wenyue
    Dai, Qigang
    Wu, Hui
    Miao, Yang
    Huang, Lei
    Liu, Qing
    Zhang, Xuyao
    Wang, Hongxia
    Liu, Yanan
    Zhang, Linlin
    ONCOTARGETS AND THERAPY, 2024, 17 : 629 - 642
  • [22] The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
    Zheng, Hao-Ran
    Jiang, Ai-Min
    Gao, Huan
    Liu, Na
    Zheng, Xiao-Qiang
    Fu, Xiao
    Zhang, Rui
    Ruan, Zhi-Ping
    Tian, Tao
    Liang, Xuan
    Yao, Yu
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2273 - 2287
  • [23] Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting
    Li, Jianjie
    Chi, Yujia
    Cao, Guang
    Zhao, Jun
    An, Tongtong
    Wu, Meina
    Wang, Yuyan
    Zhuo, Minglei
    Yang, Xue
    Jia, Bo
    Chen, Hanxiao
    Wang, Jingjing
    Zhai, Xiaoyu
    Wang, Ziping
    JOURNAL OF THORACIC DISEASE, 2021, 13 (03) : 1813 - 1821
  • [24] Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study
    Cavaille, Francois
    Peretti, Mathieu
    Garcia, Marie Eve
    Giorgi, Roch
    Ausias, Nathalie
    Vanelle, Patrice
    Barlesi, Fabrice
    Montana, Marc
    TUMORI JOURNAL, 2021, 107 (01): : 32 - 38
  • [25] Real-world treatment patterns of non-small cell lung cancer in an Indian hospital
    Miyasato, Gavin
    Kasivajjala, Vamsi Chandra
    Misra, Mohit
    Kumar, Kiran
    Shah, Chitrang
    Friedman, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Real-world treatment sequencing in advanced non-small cell lung cancer (aNSCLC).
    Radtchenko, Janna
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
    Thakrar, D. B.
    Essang, B.
    Echlin, A.
    Murdock, C.
    Lind, M. J.
    LUNG CANCER, 2019, 127 : S40 - S41
  • [28] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
  • [29] Stage IV non-small cell lung cancer in the elderly: Real-world data
    Monteiro, J. C.
    Amorim Costa, C.
    Rebordao Pires, M.
    Caetano, A. C.
    Salgueiro, F. R.
    Domingues, I.
    Meira Garcia, A. R.
    Jesus, E.
    Bonito, N. A.
    Sousa, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S769 - S769
  • [30] REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Lin, H. M.
    Pan, X.
    Hou, P.
    Huang, H.
    Baumann, P.
    Jahanzeb, M.
    VALUE IN HEALTH, 2019, 22 : S115 - S115
12345